Phonocardiography Instrument Market Size, Share, Growth, And Industry Analysis, By Type (Wire Type, Wireless Type), By Application (Medical, Home), Regional Insights and Forecast From 2025 To 2033

• 

   Request a Free Sample To Get More Information on this Market

PHONOCARDIOGRAPHY INSTRUMENT MARKET REPORT OVERVIEW

Global phonocardiography instrument market size, valued at USD 0.08 billion in 2024, is expected to climb to USD 0.24 billion by 2033 at a CAGR of 13.9% during the forecast period.

A phonocardiogram (or PCG) is a high-fidelity recording of the noises and murmurs produced by the heart using an equipment called a phonocardiograph. A phonocardiograph instrument is a device used to make a sound phonocardiogram, graphic record, or sound created by the human heart. It enables high-fidelity recording of heart murmurs and breathing sounds. A phonocardiograph instrument is a non-invasive way to obtain a phonocardiogram of the human heart.

For important cardiac procedures involving several devices, the surgeon employs integrated cardiology devices. These sophisticated instruments are utilised for early detection and treatment of cardiovascular disorders. The rising frequency of cardiovascular illnesses, a growing senior population that is more susceptible to chronic sickness, rising healthcare spending, and an increase in the number of minimally invasive procedures performed are all driving factors in the global integrated cardiology devices market.

COVID-19 IMPACT

"COVID-19 pandemic causing disruption in medical device manufacture hence reduced market growth"

The COVID-19 pandemic has been unprecedented and staggering, with the Phonocardiography Instrument Market experiencing higher/lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

COVID-19 has an impact on the global phonocardiograph market. Because of the disruption in medical device manufacture. Simultaneously, COVID-19 is predicted to drive market expansion. Auscultation of the chest, for example, is crucial in COVID-19 patients, particularly those with poor respiratory conditions such as severe pneumonia and respiratory dysfunction, as well as intense cases who are intubated and whose breathing is aided by a ventilator. However, accurate auscultation of these patients is challenging when medical personnel are wearing personal protection equipment and have limited interaction with patients. As a result, to avoid touch during diagnostic procedures, the phonocardiograph is predicted to boost market expansion during the projection period. Because of its efficacy in its application, the coronavirus pandemic had a significant impact on the integrated cardiac surgical devices market. The introduction of COVID-19 brought about substantial operational changes in the way devices are made and supplied.

LATEST TRENDS

"Electrocardiogram (ECG) is expected to account for a sizable market share in the Diagnostic and Monitoring Devices segment"

Because of the latest generation of lightweight and compact devices, which are especially popular in the home healthcare sector, more individuals are utilising ECGs for diagnostic and monitoring purposes. Continuous ECG monitoring is required due to rising prevalence of cardiovascular disease (CVD). Philips, for example, started selling a 12-lead electrocardiogram (ECG) solution for use in decentralised clinical trials that could be done in the comfort of a patient's own home in January 2022. Furthermore, an increase in research and development activities by leading market competitors, as well as an increase in unhealthy lifestyles, are functioning as possibilities for market expansion. According to the World Health Organisation, heart disorders account for around 30% of all fatalities worldwide.

PHONOCARDIOGRAPHY INSTRUMENT MARKET SEGMENTATION

By Type

According to type, the market can be segmented into Wire Type, Wireless Type. Wire Type is anticipated to be the leading segment.

By Application

Based on application, the market can be divided into Medical, Home. Medical will be the dominating segment.

DRIVING FACTORS

"In the projected term, the increased prevalence of cardiovascular disorders is expected to drive the worldwide phonocardiograph market"

Cardiovascular disorders are the major cause of death worldwide. In 2019, an estimated 17.9 million individuals died from CVDs, accounting for 32% of all global deaths. Heart attacks and strokes were responsible for 85% of these deaths. Congenital heart disease is a cardiac ailment that causes devastating symptoms such as increased morbidity, mortality, lower quality of life, and increased healthcare costs. The most frequent types of CHD are Arterial Septal Defects (ASDs) and Ventricular Septal Defects (VSDs). With an early diagnosis, Congenital heart disease can be controlled before it progresses to a critical stage. The phonocardiogram (PCG), also known as heart sound auscultation, is a simple and non-invasive test that can detect subtle differences in various CHDs. Due to human hearing limits and the non-stationary nature of PCGs, diagnosing heart sounds is difficult and requires a high level of medical expertise and skills. In the diagnosis of CHDs, an automated computer-aided approach may improve the diagnostic objectivity and consistency of PCG signals. Heart-sound auscultation is an art as much as a science. The science of noises associated with a specific heart condition is well established. Although time-frequency approaches have been used to analyse the phonocardiogram, the capacity to distinguish or recognise the sounds being heard is perhaps the art.

"Innovation of the phonocardiograph device is projected to promote the growth of the global phonocardiograph market"

The examination of heart sounds is a regularly utilised approach for identifying cardiac disorders. The availability of digital stethoscopes enables medical personnel to record and analyse heart sounds for diagnostic purposes. The phonocardiogram is a plot that records cardiac sounds and murmurs. The phonocardiograph is the gadget that records these sounds. It is one of the less noticeable systems that captures heart problems in auditory form. The opening and closing of the heart valves produces heart sounds. Heart sounds are produced by blood flow via the orifices of the valves or into the ventricular chambers. The PCG signal is composed of four major cardiac sound constituents: S1, S2, S3, and S4. Electrocardiography (ECG)-synchronized digital subtraction and spectrographic analysis, for example, can be utilised to analyse heart sounds and murmurs in novel ways.

RESTRAINING FACTORS

"Disadvantages of phonocardiography are expected to stymie the market"

Cardiac sounds are non-stationary signals that occur in the low-frequency region, between 10 and 750 Hz. The study of cardiac sounds based simply on the human ear continues to be insufficient for a meaningful diagnosis of cardiac diseases and for a clinician to gather all qualitative and quantitative information about heart activity, particularly in the field of time intervals. The amount of internal components of the heart sounds, their temporal localisation, frequency content, and the significance of diastolic and systolic murmurs may all be evaluated directly on the PCG signal. The extreme sensitivity of maternal movements to different types of noise created by this technology, however, necessitates frequent repositioning of the ultrasonic transducers. This technology does not appear to be suited for long-term continuous foetal monitoring due to the possibly detrimental effects of ultrasonic radiation on the foetus.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

PHONOCARDIOGRAPHY INSTRUMENT MARKET REGIONAL INSIGHTS

"North American region is predicted to have the greatest market share during forecast period"

In the worldwide phonocardiograph market, the North American region is predicted to have the greatest market share. The rising prevalence of chronic heart disease, increased need for diagnosis, and increased FDA approvals are projected to drive market expansion in this region. For example, an estimated 16.3 million Americans aged 20 and older have CHD, representing a 7% prevalence. Men have a 8.3 percent prevalence, whereas women have a 6.1 percent prevalence. Heart disease is the top cause of death in the United States for women, men, and people of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 36 seconds. Every year, over 655,000 Americans die from heart disease, accounting for one out of every four deaths.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

List of Top Phonocardiography Instrument Companies

• 3M Littmann (U.S.)
• Thinklabs (U.S.)
• HD Medical Group (U.S.)
• IMEDIPLUS (U.S.)
• eKuore (Spain)
• SMART SOUND (South Korea)
• Wenxin Tech (China)
• Minttihealth (China)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.